Details Basic Details Status Ongoing Last Updated Wednesday, July 29, 2026 Original Posting Date Monday, April 6, 2026 Health Outcome(s) gastrointestinal hypomotility, gastrointestinal (GI) hypomotility, constipation, or GI dysmotility with serious complications Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR No Analytic Code Link(s) (1) Risk of Gastrointestinal Hypomotility, Constipation, or GI dysmotility with Serious Complications, and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis Result(s) (1) Risk of Gastrointestinal Hypomotility, Constipation, or GI dysmotility with Serious Complications, and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis